SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-18-124877
Filing Date
2018-04-20
Accepted
2018-04-20 16:09:03
Documents
5
Effectiveness Date
2018-04-20

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS d491202ddefa14a.htm DEFA14A 17106
2 GRAPHIC g491202g26b10.jpg GRAPHIC 21032
3 GRAPHIC g491202g45j70.jpg GRAPHIC 97449
4 GRAPHIC g491202g71x02.jpg GRAPHIC 369299
5 GRAPHIC g491202g83z93.jpg GRAPHIC 193398
  Complete submission text file 0001193125-18-124877.txt   923389
Mailing Address 1035 O'BRIEN DRIVE MENLO PARK CA 94025
Business Address 1035 O'BRIEN DRIVE MENLO PARK CA 94025 650-272-6269
Adverum Biotechnologies, Inc. (Filer) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36579 | Film No.: 18766763
SIC: 2836 Biological Products, (No Diagnostic Substances)